prevention

  1. SNT Gatchaman

    The use of oral anticoagulation at the time of acute COVID-19 infection and subsequent development of [long-COVID], 2025, Frost+

    The use of oral anticoagulation at the time of acute COVID-19 infection and subsequent development of long-COVID/post-acute sequelae of SARS-CoV-2 infection Frost, Freddy; Rivera-Caravaca, José Miguel; Lip, Gregory Y. H. Long COVID (LC) or post-acute sequelae of SARS-CoV-2 infection (PASC) is...
  2. SNT Gatchaman

    Impact of treatment of COVID-19 with sotrovimab on post-acute sequelae of COVID-19 PASC…, 2025, Drysdale+

    Impact of treatment of COVID-19 with sotrovimab on post-acute sequelae of COVID-19 PASC: an analysis of National COVID Cohort Collaborative N3C data Drysdale, Myriam; Chang, Rose; Guo, Tracy; Duh, Mei Sheng; Han, Jennifer; Birch, Helen; Sharpe, Catherine; Liu, Daisy; Kalia, Sarah; Van Dyke...
  3. ahimsa

    COVID 5 years later: Learning from a pandemic many are forgetting (ScienceInsider)

    COVID 5 years later: Learning from a pandemic many are forgetting Five years after SARS-CoV-2 surfaced, scientists reflect and look ahead to the next threat https://www.science.org/content/article/covid-5-years-later-learning-pandemic-many-are-forgetting (I added some line breaks and bolding...
  4. J

    Therapeutic BCG vaccine protects against long COVID: The BATTLE randomized clinical trial 2024 Jalalizadeh

    https://onlinelibrary.wiley.com/doi/10.1111/joim.20033 Abstract Background Bacillus Calmette–Guérin (BCG) injected during the COVID-19 convalescence period was safe and enhanced recovery from anosmia and dysgeusia in the acute phase. Objectives To report the long-term results of the BATTLE...
  5. ahimsa

    Scientific American: A Fight About Viruses in the Air Is Finally Over. Now It’s Time for Healthy Venting

    [I think this belongs here - please move if necessary] A Fight About Viruses in the Air Is Finally Over. Now It’s Time for Healthy Venting https://www.scientificamerican.com/article/a-fight-about-viruses-in-the-air-is-finally-over-now-its-time-for-healthy/
  6. ahimsa

    USA - Marketplace (radio): Protecting yourself from COVID-19 these days is hard. And it comes at a cost.

    Protecting yourself from COVID-19 these days is hard. And it comes at a cost. https://www.marketplace.org/2024/03/20/protecting-yourself-from-covid-19-these-days-is-hard-and-it-comes-at-a-cost/
  7. ahimsa

    Scientific American: Rampant COVID Poses New Challenges in the Fifth Year of the Pandemic

    Rampant COVID Poses New Challenges in the Fifth Year of the Pandemic “We’re still in a pandemic,” says a lead COVID official with the World Health Organization https://www.scientificamerican.com/article/rampant-covid-poses-new-challenges-in-the-fifth-year-of-the-pandemic/ (some extra line...
  8. E

    Effectiveness of Nirmatrelvir–Ritonavir Against the Development of Post–COVID-19 Conditions Among U.S. Veterans, 2023, Ioanou et al

    Effectiveness of Nirmatrelvir–Ritonavir Against the Development of Post–COVID-19 Conditions Among U.S. Veterans Background: COVID-19 has been linked to the development of many post–COVID-19 conditions (PCCs) after acute infection. Limited information is available on the effectiveness of oral...
  9. T

    Cochrane: Physical interventions to interrupt or reduce the spread of respiratory viruses, 2023, Jefferson et al

    Physical interventions to interrupt or reduce the spread of respiratory viruses Background Viral epidemics or pandemics of acute respiratory infections (ARIs) pose a global threat. Examples are influenza (H1N1) caused by the H1N1pdm09 virus in 2009, severe acute respiratory syndrome (SARS) in...
  10. E

    Nirmatrelvir/ritonavir and risk of long COVID symptoms: A retrospective cohort study, 2023, Congdon et al

    Nirmatrelvir/ritonavir and risk of long COVID symptoms: A retrospective cohort study We conducted a retrospective cohort study to assess whether treatment with nirmatrelvir/ritonavir was associated with a reduced risk of long COVID. We enrolled 500 adults with confirmed SARS-CoV-2 who were...
  11. ahimsa

    Opinion: Let’s approach COVID like the weather. Depending on conditions, we grab an umbrella (or mask) - The Philadelphia Inquirer

    New op-ed in The Philadelphia Inquirer by Jennie Spotila: Let’s approach COVID like the weather. Depending on conditions, we grab an umbrella (or mask) Tweet from the author:
  12. Sly Saint

    The feasibility and acceptability of an early intervention in primary care to prevent CFS in adults: randomised controlled-O'Dowd, Crawley 2020

    The feasibility and acceptability of an early intervention in primary care to prevent chronic fatigue syndrome (CFS) in adults: randomised controlled trial https://pilotfeasibilitystudies.biomedcentral.com/articles/10.1186/s40814-020-00595-0
  13. John Mac

    How ME/CFS Progresses: A Framework for Research and the Prevention, Treatment, and Rehabilitation in ME/CFS Nacul et al 2019

    https://www.preprints.org/manuscript/201909.0188/v1
Back
Top Bottom